Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1990-06-18
1992-06-23
Nutter, Nathan M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514255, A01N 4360, A61K 31495
Patent
active
051243300
ABSTRACT:
Potentiating agents which enhance the efficacy of antineoplastic agents are disclosed. The potentiating agents disclosed are piperazinyl benzyl compounds such as 1-[.alpha.-(4-chlorophenyl)-3-methoxybenzyl]-4-allylpiperazine dihydrochloride.
REFERENCES:
patent: 3996222 (1976-12-01), Kajfez et al.
patent: 4628047 (1986-12-01), Sakurai et al.
patent: 4757074 (1988-07-01), Coker et al.
patent: 4990538 (1991-02-01), Harris et al.
Wilson, C. M. et al., "Amplification of a Gene Related to Mammalian mdr Genes in Drug-Resistant Plasmodium falciparum," Science 244, 1184 (1989).
"The Merck Index," p. Misc-2 (11th Ed. 1989).
Burroughs Wellcome Company
Nutter Nathan M.
LandOfFree
(E)-ethyl 3-(4-chloro-.alpha.-(4-methyl-1-piperazinyl)benzyl)cin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with (E)-ethyl 3-(4-chloro-.alpha.-(4-methyl-1-piperazinyl)benzyl)cin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and (E)-ethyl 3-(4-chloro-.alpha.-(4-methyl-1-piperazinyl)benzyl)cin will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-932954